OceanBase Hosts Technical Symposium on Data x AI and Has Six Papers Accepted at ICDE 2025
In the symposium, Charlie Yang, Chief Technology Officer of OceanBase, presented OceanBase's vision for an AI-ready data infrastructure, emphasizing its commitment to empowering intelligent, scalable, and resilient data ecosystems. Notable professors, researchers and experts from The Chinese University of Hong Kong, The Hong Kong University of Science and Technology (Guangzhou), Northeastern University, and OneConnect Financial Technology (Hong Kong), shared their research findings and industry insights around data x AI innovations and applications.
Meanwhile, six papers authored or contributed to by the OceanBase team were accepted at ICDE 2025. Among them, "OceanBase Unionization: Building the Next Generation of Online Map Applications," co-authored with Alibaba and Cornell University researchers, was recognized as the Best Industry and Application Paper Runner Up. This paper proposes the architectural design of OceanBase's distributed database system, which "unitizes" services and operations into individual machines, bringing stronger disaster tolerance and achieving better performance in real-world testing with AMap, an online map application platform supporting large-scale distributed services.
Serving over 2,000 customers globally, including Alipay, Pop Mart, Trip.com, GCash and DANA, OceanBase remains dedicated to advancing database technologies in today's AI-driven era. Since 2024, more than ten of its research papers have been accepted at top database conferences worldwide, including ICDE, SIGMOD, and VLDB. These papers cover a wide range of topics in distributed database technology, such as innovative algorithm for solving the fair clustering problem, Paxos-backed Append-only Log File (PALF) system, and functionality-aware database tuning.
Since its inception in 2010, OceanBase has actively collaborated with esteemed universities and research institutes such as East China Normal University, Renmin University of China, Wuhan University, and Nanyang Technological University in Singapore, to explore the forefront of database technologies. These collaborations involve establishing joint laboratories, pursuing research projects, and co-hosting database competitions.
Moreover, OceanBase has partnered with institutions like Ant Research and the China Computer Federation to establish funds to conduct in-depth research on major technical challenges for modern databases, including "stand-alone and distributed integrated architecture," "transaction processing and analytical processing (TP and AP) integration," "storage-computing separation," and "database performance optimization", and bring scientific research into real-world applications.
About OceanBase
OceanBase is a distributed database launched in 2010. It provides strong data consistency, high availability, high performance, cost efficiency, elastic scalability, and compatibility with mainstream relational databases. It handles transactional, analytical, and AI workloads through a unified data engine, enabling mission-critical applications and real-time analytics.
To learn more, please visit: https://www.oceanbase.com/
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/oceanbase-hosts-technical-symposium-on-data-x-ai-and-has-six-papers-accepted-at-icde-2025-302464033.html
SOURCE OceanBase
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Prologis Reports Second Quarter 2025 Results
Resilient performance through volatile environment SAN FRANCISCO, July 16, 2025 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD) today announced the following results for the quarter ended June 30, 2025, as compared to the corresponding period in 2024: Net earnings per diluted share was $0.61 and decreased 33.7% due to lower gains and unrealized FX. Core funds from operations (Core FFO)* per diluted share was $1.46 and increased 9.0%. Core FFO, excluding Net Promote Income (Expense)* per diluted share was $1.47 and increased 8.1%. Hamid R. Moghadam, co-founder and CEO of Prologis, commented: "Our teams performed exceptionally in our operations and deployment activity over the quarter. This success stems from strong execution, staying close to customers, and the long-term fundamentals of our business." "Our leasing pipeline has reached historically high levels, and what we're hearing from customers, especially the larger ones, is clear: they're planning, engaging and increasingly ready to act," said Daniel S. Letter, president of Prologis. "These trends are evident in both our leasing and build-to-suit activity—and we're in a strong position to meet that demand." OPERATING PERFORMANCE Owned & Managed 2Q25 Average Occupancy 94.9 % Period End Occupancy 95.1 % Leases Commenced (Operating and Development Portfolio) 51.2 MSF Retention 74.9 % Prologis Share 2Q25 Average Occupancy 94.8 % Cash Same Store NOI* 4.9 % Net Effective Rent Change 53.4 % Cash Rent Change 34.8 % DEPLOYMENT ACTIVITY Prologis Share 2Q25 Acquisitions $335M Weighted avg stabilized cap rate (excluding other real estate) 5.7 % Development Stabilizations $192M Estimated weighted avg yield 6.9 % Estimated weighted avg margin 33.2 % Estimated value creation $64M % Build-to-suit 5.3 % Development Starts $846M Estimated weighted avg yield 6.3 % Estimated weighted avg margin 21.4 % Estimated value creation $181M % Build-to-suit 62.7 % Total Dispositions and Contributions $96M Weighted avg stabilized cap rate (excluding land and other real estate) 4.5 % BALANCE SHEET STRENGTH & LIQUIDITYDuring the quarter, the company: Issued, together with its co-investment ventures, an aggregate of $5.8 billion of debt at a weighted average interest rate of 4.5% and a weighted average term of 5.4 years. This activity included the extension of the maturity date of the company's $3.0 billion revolving line of credit. As of quarter-end: Total available liquidity was approximately $7.1 billion. Debt-to-EBITDA* was 5.1x and debt as a percentage of total market capitalization was 27.9%. The weighted average interest rate on the company's share of total debt was 3.2%, with a weighted average term of 8.5 years. Forecasted earnings for 2025, 2026 and 2027 are 99%, 98% and 98%, respectively, in USD or hedged through derivative contracts and 96% of Prologis' equity was in USD. 2025 GUIDANCE Prologis' guidance for net earnings is included in the table below as well as guidance for Core FFO*, which are reconciled in our supplemental information. "The increase in our guidance reflects our confidence in the strength and resilience of our business," said Timothy D. Arndt, chief financial officer of Prologis. "Our teams are executing at a high level, and we're well-positioned for the remainder of the year." 2025 GUIDANCE Earnings (per diluted share) Previous Revised Net earnings attributable to common stockholders $3.45 to $3.70 $3.00 to $3.15 Core FFO attributable to common stockholders/unitholders* $5.65 to $5.81 $5.75 to $5.80 Core FFO attributable to common stockholders/unitholders, excluding Net Promote Income (Expense)* $5.70 to $5.86 $5.80 to $5.85Operations - Prologis Share Average Occupancy 94.50% to 95.50% 94.75% to 95.25% Cash Same Store NOI* 4.00% to 5.00% 4.25% to 4.75% Net Effective Same Store NOI* 3.50% to 4.50% 3.75% to 4.25%Strategic Capital (in millions) Strategic Capital revenue, excluding promote revenue $560 to $580 $570 to $590 Net Promote Income (Expense)1 $(50) $(50) G&A (in millions) Previous Revised General & administrative expenses $450 to $470 $450 to $470Capital Deployment - Prologis Share (in millions) Development stabilizations $1,900 to $2,300 $1,900 to $2,300 Development starts $1,500 to $2,000 $2,250 to $2,750 Acquisitions $750 to $1,250 $1,000 to $1,250 Contributions $150 to $500 $500 to $1,000 Dispositions $250 to $500 $500 to $750 Realized development gains $100 to $250 $150 to $250 1. Net promote expense relates to amortization of stock compensation issued to employees related to promote income recognized in prior periods. * This is a non-GAAP financial measure. See the Notes and Definitions in our supplemental information for further explanation and a reconciliation to the most directly comparable GAAP measure. The earnings guidance described above includes potential gains recognized from real estate transactions but excludes any future or potential foreign currency or derivative gains or losses as our guidance assumes constant foreign currency rates. In reconciling from net earnings to Core FFO*, Prologis makes certain adjustments, including but not limited to real estate depreciation and amortization expense, gains (losses) recognized from real estate transactions and early extinguishment of debt, impairment charges, deferred taxes and unrealized gains or losses on foreign currency or derivative activity. The difference between the company's Core FFO* and net earnings guidance relates predominantly to these items. Please refer to our quarterly Supplemental Information, which is available on our Investor Relations website at and on the SEC's website at for a definition of Core FFO* and other non-GAAP measures used by Prologis, along with reconciliations of these items to the closest GAAP measure for our results and guidance. July 16, 2025, CALL DETAILS The call will take place on Wednesday, July 16, 2025, at 9:00 a.m. PT/12:00 p.m. ET. To access a live broadcast of the call, please dial +1 (877) 897-2615 (toll-free from the United States and Canada) or +1 (201) 689-8514 (from all other countries). A live webcast can be accessed from the Investor Relations section of A telephonic replay will be available July 16 – July 30 at +1 (877) 660-6853 (from the United States and Canada) or +1 (201) 612-7415 (from all other countries) using access code 13750493. The webcast replay will be posted in the Investor Relations section of under "Events & Presentations." ABOUT PROLOGISThe world runs on logistics. At Prologis, we don't just lead the industry, we define it. We create the intelligent infrastructure that powers global commerce, seamlessly connecting the digital and physical worlds. From agile supply chains to clean energy solutions, our ecosystems help your business move faster, operate smarter and grow sustainably. With unmatched scale, innovation and expertise, Prologis is a category of one–not just shaping the future of logistics but building what comes next. Learn more at FORWARD-LOOKING STATEMENTSThe statements in this document that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which we operate as well as management's beliefs and assumptions. Such statements involve uncertainties that could significantly impact our financial results. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "aims," and "estimates" including variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future—including statements relating to rent and occupancy growth, acquisition and development activity, contribution and disposition activity, general conditions in the geographic areas where we operate, expectations regarding new lines of business, our debt, capital structure and financial position, our ability to earn revenues from co-investment ventures or form new co-investment ventures and the availability of capital in existing or new co-investment ventures—are forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and, therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. Some of the factors that may affect outcomes and results include, but are not limited to: (i) international, national, regional and local economic and political climates and conditions; (ii) changes in global financial markets, interest rates and foreign currency exchange rates; (iii) increased or unanticipated competition for our properties; (iv) risks associated with acquisitions, dispositions and development of properties, including the integration of the operations of significant real estate portfolios; (v) maintenance of Real Estate Investment Trust status, tax structuring and changes in income tax laws and rates; (vi) availability of financing and capital, the levels of debt that we maintain and our credit ratings; (vii) risks related to our investments in our co-investment ventures, including our ability to establish new co-investment ventures; (viii) risks of doing business internationally, including currency risks; (ix) environmental uncertainties, including risks of natural disasters; (x) risks related to global pandemics; and (xi) those additional factors discussed in reports filed with the Securities and Exchange Commission by us under the heading "Risk Factors." We undertake no duty to update any forward-looking statements appearing in this document except as may be required by law. dollars in millions, except per share/unit data Three Months Ended June 30,Six Months Ended June 30, 2025 20242025 2024 Rental and other revenues $ 2,037 $ 1,853$ 4,036 $ 3,682 Strategic capital revenues 147 155288 283Total revenues 2,184 2,0084,324 3,965 Net earnings attributable to common stockholders 570 8601,161 1,444 Core FFO attributable to common stockholders/unitholders* 1,396 1,2812,752 2,504 AFFO attributable to common stockholders/unitholders* 1,036 1,0722,120 2,104 Adjusted EBITDA attributable to common stockholders/unitholders* 1,789 1,7193,561 3,317 Estimated value creation from development stabilizations - Prologis Share 64 296304 346 Common stock dividends and common limited partnership unit distributions 966 9171,931 1,833Per common share - diluted: Net earnings attributable to common stockholders $ 0.61 $ 0.92$ 1.25 $ 1.55Core FFO attributable to common stockholders/unitholders* 1.46 1.342.88 2.63Core FFO attributable to common stockholders/unitholders, excluding Net PromoteIncome (Expense)* 1.47 1.362.91 2.66Business line reporting:Real estate* 1.40 1.292.76 2.54 Strategic capital* 0.06 0.050.12 0.09 Core FFO attributable to common stockholders/unitholders* 1.46 1.342.88 2.63 Realized development gains, net of taxes* 0.01 0.090.04 0.13 Dividends and distributions per common share/unit 1.01 0.962.02 1.92*This is a non-GAAP financial measure. Please see our Notes and Definitions for further explanation. in thousands June 30, 2025March 31, 2025December 31, 2024 Assets: Investments in real estate properties:Operating properties $ 80,115,830$ 79,492,052$ 78,279,353 Development portfolio 2,891,0252,596,0692,829,613 Land 4,826,7274,660,4314,453,522 Other real estate investments 6,498,9295,992,8395,683,68894,332,51192,741,39191,246,176 Less accumulated depreciation 13,827,46213,290,67812,758,159 Net investments in real estate properties 80,505,04979,450,71378,488,017Investments in and advances to unconsolidated entities 10,618,18410,287,31410,079,448Assets held for sale or contribution 253,331545,542248,511 Net investments in real estate 91,376,56490,283,56988,815,976Cash and cash equivalents 1,066,081671,1171,318,591Other assets 5,274,4055,038,7055,194,342 Total assets $ 97,717,050$ 95,993,391$ 95,328,909 Liabilities and Equity: Liabilities:Debt $ 34,666,551$ 32,262,055$ 30,879,263 Accounts payable, accrued expenses and other liabilities 5,743,6855,655,8985,832,876 Total liabilities 40,410,23637,917,95336,712,139Equity:Stockholders' equity 52,728,57453,467,21053,951,138 Noncontrolling interests 3,311,8863,320,4733,323,047 Noncontrolling interests - limited partnership unitholders 1,266,3541,287,7551,342,585 Total equity 57,306,81458,075,43858,616,770 Total liabilities and equity $ 97,717,050$ 95,993,391$ 95,328,909 Three Months EndedSix Months Ended June 30,June 30, in thousands, except per share amounts 2025 20242025 2024 Revenues: Rental $ 2,025,332 $ 1,852,376$ 4,012,597 $ 3,680,034Strategic capital 147,162 154,742288,301 283,154Development management and other 11,375 83622,636 1,387 Total revenues 2,183,869 2,007,9544,323,534 3,964,575 Expenses: Rental 487,963 445,235976,280 899,492Strategic capital 64,917 70,536125,694 149,347General and administrative 106,871 106,596221,572 217,887Depreciation and amortization 657,221 637,3051,309,279 1,274,810Other 11,706 11,44421,355 23,688 Total expenses 1,328,678 1,271,1162,654,180 2,565,224Operating income before gains on real estate transactions, net $ 855,191 $ 736,838$ 1,669,354 $ 1,399,351Gains on dispositions of development properties and land, net 10,477 87,17437,928 127,482Gains on other dispositions of investments in real estate, net 47,044 199,32683,843 216,860 Operating income $ 912,712 $ 1,023,338$ 1,791,125 $ 1,743,693 Other income (expense): Earnings from unconsolidated entities, net 107,692 102,337175,591 174,809Interest expense (251,866) (208,267)(483,617) (401,587)Foreign currency, derivative and other gains (losses) and other income (expense), net (122,829) 37,152(154,487) 100,716Gains (losses) on early extinguishment of debt, net - -- 536 Total other income (expense) (267,003) (68,778)(462,513) (125,526)Earnings before income taxes 645,709 954,5601,328,612 1,618,167Current income tax benefit (expense) (27,723) (32,888)(64,424) (65,354)Deferred income tax benefit (expense) 4,318 (10,171)(2,364) (10,505) Consolidated net earnings 622,304 911,5011,261,824 1,542,308 Net earnings attributable to noncontrolling interests (37,139) (28,802)(68,715) (59,110) Net earnings attributable to noncontrolling interests - limited partnership units (13,936) (21,351)(28,927) (36,135) Net earnings attributable to controlling interests 571,229 861,3481,164,182 1,447,063 Preferred stock dividends (1,505) (1,503)(2,957) (2,955) Net earnings attributable to common stockholders $ 569,724 $ 859,845$ 1,161,225 $ 1,444,108 Weighted average common shares outstanding - Diluted 955,882 953,200955,601 953,439 Net earnings per share attributable to common stockholders - Diluted $ 0.61 $ 0.92$ 1.25 $ 1.55 Three Months EndedSix Months Ended June 30,June 30, in thousands 2025 20242025 2024 Net earnings attributable to common stockholders $ 569,724 $ 859,845$ 1,161,225 $ 1,444,108 Add (deduct) NAREIT defined adjustments: Real estate related depreciation and amortization 638,199 617,8221,270,885 1,239,984Gains on other dispositions of investments in real estate, net of taxes (excluding development properties and land) (46,964) (198,857)(82,771) (216,391)Adjustments related to noncontrolling interests (17,339) (9,808)(35,746) (25,904)Our proportionate share of adjustments related to unconsolidated entities 133,734 101,905284,358 221,436 NAREIT defined FFO attributable to common stockholders/unitholders* $ 1,277,354 $ 1,370,907$ 2,597,951 $ 2,663,233Add (deduct) our modified adjustments: Unrealized foreign currency, derivative and other losses (gains), net 137,817 (3,035)192,715 (38,108)Deferred income tax expense (benefit) (4,318) 10,1712,364 10,505Our proportionate share of adjustments related to unconsolidated entities (3,136) (4,520)(1,765) (4,211) FFO, as modified by Prologis attributable to common stockholders/unitholders* $ 1,407,717 $ 1,373,523$ 2,791,265 $ 2,631,419Add (deduct) Core FFO defined adjustments: Gains on dispositions of development properties and land, net (10,477) (87,174)(37,928) (127,482)Current income tax expense (benefit) on dispositions 659 (493)803 4,836Losses (gains) on early extinguishment of debt, net - -- (536)Adjustments related to noncontrolling interests 2,748 782,821 78Our proportionate share of adjustments related to unconsolidated entities (4,665) (4,647)(4,948) (4,649) Core FFO attributable to common stockholders/unitholders* $ 1,395,982 $ 1,281,287$ 2,752,013 $ 2,503,666Add (deduct) AFFO defined adjustments: Gains on dispositions of development properties and land, net 10,477 87,17437,928 127,482Current income tax benefit (expense) on dispositions (659) 493(803) (4,836)Straight-lined rents and amortization of lease intangibles (187,801) (144,349)(368,162) (303,309)Property improvements (68,772) (96,112)(103,139) (126,312)Turnover costs (152,242) (111,400)(275,365) (215,706)Amortization of debt discount, financing costs and management contracts, net 22,209 20,36243,321 38,700Stock compensation amortization expense 43,984 54,54597,145 121,782Adjustments related to noncontrolling interests 18,594 11,65232,576 20,683Our proportionate share of adjustments related to unconsolidated entities (45,863) (31,547)(95,682) (57,688) AFFO attributable to common stockholders/unitholders* $ 1,035,909 $ 1,072,105$ 2,119,832 $ 2,104,462 *This is a non-GAAP financial measure. Please see our Notes and Definitions for further explanation. Three Months EndedSix Months Ended June 30,June 30, in thousands 2025 20242025 2024 Net earnings attributable to common stockholders $ 569,724 $ 859,845$ 1,161,225 $ 1,444,108 Gains on other dispositions of investments in real estate, net (excluding development propertiesand land) (47,044) (199,326)(83,843) (216,860) Depreciation and amortization expense 657,221 637,3051,309,279 1,274,810 Interest charges 235,858 193,413451,508 377,425 Current and deferred income tax expense, net 23,405 43,05966,788 75,859 Net earnings attributable to noncontrolling interests - limited partnership units 13,936 21,35128,927 36,135 Pro forma adjustments 2,481 5,81710,310 7,541 Preferred stock dividends 1,505 1,5032,957 2,955 Unrealized foreign currency, derivative and other losses (gains), net 137,817 (3,035)192,715 (38,108) Stock compensation amortization expense 43,984 54,54597,145 121,782 Losses (gains) on early extinguishment of debt, net - -- (536) Adjustments related to noncontrolling interests (31,819) (31,496)(65,669) (62,847) Our proportionate share of adjustments related to unconsolidated entities 182,264 135,926389,426 294,802 Adjusted EBITDA attributable to common stockholders/unitholders* $ 1,789,332 $ 1,718,907$ 3,560,768 $ 3,317,066*This is a non-GAAP financial measure. Please see our Notes and Definitions for further EBITDA. We use Adjusted EBITDA attributable to common stockholders/unitholders ("Adjusted EBITDA"), a non-GAAP financial measure, as a measure of our operating performance. The most directly comparable GAAP measure to Adjusted EBITDA is net earnings. We calculate Adjusted EBITDA by beginning with consolidated net earnings attributable to common stockholders and removing the effect of: interest charges, income taxes, depreciation and amortization, impairment charges, gains or losses from the disposition of investments in real estate (excluding development properties and land), gains from the revaluation of equity investments upon acquisition of a controlling interest, gains or losses on early extinguishment of debt and derivative contracts (including cash charges), similar adjustments we make to our FFO measures (see definition below), and other items, such as, amortization of stock based compensation and unrealized gains or losses on foreign currency and derivatives. We also include a pro forma adjustment to reflect a full period of NOI on the operating properties we acquire or stabilize during the quarter and to remove NOI on properties we dispose of during the quarter, assuming all transactions occurred at the beginning of the quarter. For properties we contribute, we make an adjustment to reflect NOI at the new ownership percentage for the full quarter. We believe Adjusted EBITDA provides investors relevant and useful information because it permits investors to view our operating performance, analyze our ability to meet interest payment obligations and make quarterly preferred stock dividends on an unleveraged basis before the effects of income tax, depreciation and amortization expense, gains and losses on the disposition of non-development properties and other items (outlined above), that affect comparability. While all items are not infrequent or unusual in nature, these items may result from market fluctuations that can have inconsistent effects on our results of operations. The economics underlying these items reflect market and financing conditions in the short-term but can obscure our performance and the value of our long-term investment decisions and strategies. We calculate our Adjusted EBITDA, based on our proportionate ownership share of both our unconsolidated and consolidated ventures. We reflect our share of our Adjusted EBITDA measures for unconsolidated ventures by applying our average ownership percentage for the period to the applicable adjusting items on an entity by entity basis. We reflect our share for consolidated ventures in which we do not own 100% of the equity by adjusting our Adjusted EBITDA measures to remove the noncontrolling interests share of the applicable adjusting items based on our average ownership percentage for the applicable periods. While we believe Adjusted EBITDA is an important measure, it should not be used alone because it excludes significant components of net earnings, such as our historical cash expenditures or future cash requirements for working capital, capital expenditures, distribution requirements, contractual commitments or interest and principal payments on our outstanding debt and is therefore limited as an analytical tool. Our computation of Adjusted EBITDA may not be comparable to EBITDA reported by other companies in both the real estate industry and other industries. We compensate for the limitations of Adjusted EBITDA by providing investors with financial statements prepared according to GAAP, along with this detailed discussion of Adjusted EBITDA and a reconciliation to Adjusted EBITDA from consolidated net earnings attributable to common stockholders. Business Line Reporting is a non-GAAP financial measure. Core FFO and development gains are generated by our three lines of business: (i) real estate operations; (ii) strategic capital; and (iii) development. The real estate operations line of business represents total Prologis Core FFO, less the amount allocated to the strategic capital line of business. The amount of Core FFO allocated to the strategic capital line of business represents the third-party share of asset management fees and transactional fees that we earn from our consolidated and unconsolidated co-investment ventures less costs directly associated with our strategic capital group and Net Promote Income (Expense). Realized development gains include our share of gains on dispositions of development properties and land, net of taxes. To calculate the per share amount, the amount generated by each line of business is divided by the weighted average diluted common shares outstanding used in our Core FFO per share calculation. Management believes evaluating our results by line of business is a useful supplemental measure of our operating performance because it helps the investing public compare the operating performance of Prologis' respective businesses to other companies' comparable businesses. Prologis' computation of FFO by line of business may not be comparable to that reported by other real estate companies as they may use different methodologies in computing such measures. Calculation of Per Share AmountsThree Months EndedSix Months EndedJun. 30,Jun. 30, in thousands, except per share amount 2025202420252024 Net earnings Net earnings attributable to common stockholders $ 569,724$ 859,845$ 1,161,225$ 1,444,108 Noncontrolling interest attributable to exchangeable limited partnership units 13,93621,55128,92736,516 Adjusted net earnings attributable to common stockholders - Diluted $ 583,660$ 881,396$ 1,190,152$ 1,480,624 Weighted average common shares outstanding - Basic 928,476926,276927,909925,812 Incremental weighted average effect on exchange of limited partnership units 22,73123,22423,11523,465 Incremental weighted average effect of equity awards 4,6753,7004,5774,162 Weighted average common shares outstanding - Diluted 955,882953,200955,601953,439 Net earnings per share - Basic $ 0.61$ 0.93$ 1.25$ 1.56 Net earnings per share - Diluted $ 0.61$ 0.92$ 1.25$ 1.55Three Months EndedSix Months EndedJun. 30,Jun. 30, in thousands, except per share amount 2025202420252024 Core FFO Core FFO attributable to common stockholders/unitholders $ 1,395,982$ 1,281,287$ 2,752,013$ 2,503,666 Noncontrolling interest attributable to exchangeable limited partnership units 258289552564 Core FFO attributable to common stockholders /unitholders - Diluted $ 1,396,240$ 1,281,576$ 2,752,565$ 2,504,230 Net Promote Income (Expense) (13,437)(11,315)(24,330)(34,056) Core FFO attributable to common stockholders /unitholders, excluding Net Promote Income(Expense) - Diluted $ 1,409,677$ 1,292,891$ 2,776,895$ 2,538,286 Weighted average common shares outstanding - Basic 928,476926,276927,909925,812 Incremental weighted average effect on exchange of limited partnership units 22,99023,22423,38323,465 Incremental weighted average effect of equity awards 4,6753,7004,5774,162 Weighted average common shares outstanding - Diluted 956,141953,200955,869953,439 Core FFO per share - Diluted $ 1.46$ 1.34$ 2.88$ 2.63 Core FFO per share, excluding Net Promote Income (Expense) - Diluted $ 1.47$ 1.36$ 2.91$ 2.66 Development Portfolio includes industrial and non-industrial properties, data centers, yards and parking lots that are under development and properties that are developed but have not met Stabilization. At June 30, 2025, total TEI for yards, parking lots, data centers and non-industrial assets was $1.2 billion and $1.1 billion on an Owned and Managed and Prologis Share basis, respectively. We do not disclose square footage for yards and parking lots. Estimated Value Creation represents the value that we expect to create through our development and leasing activities. We calculate Estimated Value Creation by estimating the Stabilized NOI that the property will generate and applying a stabilized capitalization rate applicable to that property. Estimated Value Creation is calculated as the amount by which the value exceeds our TEI, including closing costs and taxes, if any, and does not include any fees or promotes we may earn. Estimated Weighted Average Margin is calculated on development properties as Estimated Value Creation, less estimated closing costs and taxes, if any, on properties expected to be sold or contributed, divided by TEI. Estimated Weighted Average Stabilized Yield is calculated on the properties in the Development Portfolio as Stabilized NOI divided by TEI. The yields on a Prologis Share basis were as follows:Pre-Stabilized Developments 2025 Expected Completion 2026 and Thereafter Expected Completion Total Development Portfolio U.S. 6.6 % 7.4 % 6.9 % 6.9 % Other Americas 7.8 % 7.6 % 7.9 % 7.8 % Europe 5.8 % 6.8 % 5.6 % 5.9 % Asia 4.5 % 5.8 % 4.9 % 4.9 % Total 6.4 % 7.2 % 6.2 % 6.5 % FFO, as modified by Prologis attributable to common stockholders/unitholders ("FFO, as modified by Prologis"); Core FFO attributable to common stockholders/unitholders ("Core FFO"); AFFO attributable to common stockholders/unitholders ("AFFO"); (collectively referred to as "FFO"). FFO is a non-GAAP financial measure that is commonly used in the real estate industry, with net earnings as the most directly comparable GAAP measure. The National Association of Real Estate Investment Trusts ("NAREIT") defines FFO as earnings computed under GAAP to exclude depreciation and gains and losses from sales net of any related tax, along with impairment charges, of previously depreciated properties. This measure excludes the gains on revaluation of equity investments upon acquisition of a controlling interest and the gain recognized from a partial sale of our investment, as these are similar to gains from the sales of previously depreciated properties. This measure excludes similar adjustments from our unconsolidated entities and the third parties' share of our consolidated ventures. Our FFO Measures Our FFO measures begin with NARElT's definition, with certain adjustments to calculate FFO, as modified by Prologis, and Core FFO, both as defined below, to reflect our business and execution of our management strategy. While these adjustments are subject to significant fluctuations from period to period, with both positive and negative short-term impacts, the removal of the effects of these items enhances our understanding of the core operating performance of our properties over the long term. We use FFO, as modified by Prologis, so that management, analysts and investors are able to evaluate our performance against other REITs that do not have similar operations or operations in jurisdictions outside the U.S. We use both Core FFO and AFFO to (i) assess our operating performance as compared to other real estate companies; (ii) evaluate our performance and the performance of our properties in comparison with expected results and results of previous periods; (iii) evaluate the performance of our management; (iv) budget and forecast future results to assist in the allocation of resources; and (v) evaluate how a specific potential investment will impact our future results. We calculate our FFO measures based on our proportionate ownership share of both our unconsolidated entities and consolidated ventures. We reflect our share of our FFO measures for unconsolidated entities by applying our average ownership percentage for the period to the applicable adjustments on an entity-by-entity basis. We reflect our share for consolidated ventures in which we do not own 100% of the equity by removing the noncontrolling interests share of the applicable adjustments based on our average ownership percentage for the applicable periods. FFO, as modified by Prologis To arrive at FFO, as modified by Prologis, we adjust the NAREIT defined FFO measure to exclude: (I) deferred income tax benefits and deferred income tax expenses recognized by our subsidiaries; (II) current income tax expense related to acquired tax liabilities that were recorded as deferred tax liabilities in an acquisition, to the extent the expense is offset with a deferred income tax benefit in earnings that is excluded from our defined FFO measure; and (III) foreign currency exchange gains and losses resulting from (a) debt transactions between us and our foreign entities; (b) third-party debt that is used to hedge our investment in foreign entities; (c) derivative financial instruments related to any such debt transactions; and (d) mark-to-market adjustments associated with derivative and other financial instruments. Core FFO To arrive at Core FFO, we adjust FFO, as modified by Prologis, to exclude the following: (I) gains or losses from the disposition of land and development properties that were developed with the intent to contribute or sell; (II) income tax expense related to the sale of investments in real estate; (III) impairment charges recognized related to our investments in real estate generally as a result of our change in intent to contribute or sell these properties; and (IV) gains or losses from the early extinguishment of debt and redemption and repurchase of preferred stock. AFFO To arrive at AFFO, we adjust Core FFO to include realized gains from the disposition of land and development properties, net of current tax expense, and recurring capital expenditures and exclude the following items that we recognize directly in Core FFO: (I) straight-line rents; (II) amortization of above- and below-market lease intangibles; (III) amortization of management contracts; (IV) amortization of debt premiums and discounts and financing costs, net of amounts capitalized, and; (V) stock compensation amortization expense. Limitations on the use of our FFO measures While we believe our modified FFO measures are important supplemental measures for our stockholders, potential investors and financial analysts to understand, we do not use NAREIT's nor our measures of FFO as alternatives to net earnings computed under GAAP, as indicators of our operating performance, as alternatives to cash from operating activities computed under GAAP or as indicators of our ability to fund our cash needs. These measures should be read with our complete Consolidated Financial Statements prepared under GAAP. To assist investors in compensating for these limitations, we reconcile our modified FFO measures to our net earnings computed under GAAP. Guidance. The following is a reconciliation of our annual guided Net Earnings per share to our guided Core FFO per share:LowHighNet earnings attributable to common stockholders (a) $ 3.00$ 3.15Our share of: Depreciation and amortization3.07 3.10Net gains on real estate transactions, net of taxes(0.54) (0.67)Unrealized foreign currency losses (gains), losses (gains) on early extinguishment of debt and other, net0.22 0.22Core FFO attributable to common stockholders/unitholders $ 5.75$ 5.80Less: Net Promote Expense (Income)0.05 0.05Core FFO attributable to common stockholders/unitholders, excluding Net Promote Income (Expense) $ 5.80$ 5.85(a) Earnings guidance includes potential future gains recognized from real estate transactions, but excludes future foreign currency or derivative gains or losses as these items are difficult to predict. Market Capitalization equals Market Equity, less liquidation preference of the preferred shares/units, plus our share of total debt. Net Promote Income (Expense) is promote revenue earned from third-party investors during the period, net of related cash and stock compensation expenses, and taxes and foreign currency derivative gains and losses, if applicable. Operating Portfolio represents industrial properties in our Owned and Managed portfolio that have reached Stabilization. Assets held for sale, Non-Strategic Assets and non-industrial assets are excluded from the portfolio. Prologis Share of NOI excludes termination fees and adjustments and includes NOI for the properties contributed to or acquired from co-investment ventures at our actual share prior to and subsequent to change in ownership. The U.S. markets not presented consist of Austin, Charlotte, Columbus, Denver, Louisville, Portland, Raleigh-Durham, Reno, San Antonio, Savannah and Tampa. The European countries not presented consist of Belgium, Czech Republic, Hungary, Italy, Poland, Slovakia, Spain and Sweden. Owned and Managed represents the consolidated properties as well as properties owned by our unconsolidated co-investment ventures, which we manage. Prologis Share represents our proportionate economic ownership of each entity, or property included in our total Owned and Managed portfolio, whether consolidated or unconsolidated. Rent Change (Cash) represents the percentage change in starting rental rates per the lease agreement, on new and renewed leases, commenced during the period compared with the previous ending rental rates in that same space. This measure excludes any short-term leases of less than one-year, holdover payments, free rent periods and introductory (teaser rates) defined as 50% or less of the stabilized rate. Rent Change (Net Effective) represents the percentage change in net effective rental rates (average rate over the lease term), on new and renewed leases, commenced during the period compared with the previous net effective rental rates for the same respective spaces. This measure excludes any short-term leases of less than one year and holdover payments. Retention is the square footage of all leases commenced during the period that are rented by existing tenants divided by the square footage of all expiring leases during the reporting period. The square footage of tenants that default or buy-out prior to expiration of their lease and short-term leases of less than one year, are not included in the calculation. Same Store. Our same store metrics are non-GAAP financial measures, which are commonly used in the real estate industry and expected from the financial community, on both a net effective and cash basis. We evaluate the performance of the operating properties we own and manage using a "same store" analysis because the population of properties in this analysis is consistent from period to period, which allows us and investors to analyze our ongoing business operations. We determine our same store metrics on property NOI, which is calculated as rental revenue less rental expense for the applicable properties in the same store population for both consolidated and unconsolidated properties based on our ownership interest, as further defined below. We define our same store population for the three months ended June 30, 2025 as the properties in our Owned and Managed Operating Portfolio, including the property NOI for both consolidated properties and properties owned by the unconsolidated co-investment ventures at January 1, 2024 and owned throughout the same three-month period in both 2024 and 2025. We believe the drivers of property NOI for the consolidated portfolio are generally the same for the properties owned by the ventures in which we invest and therefore we evaluate the same store metrics of the Owned and Managed portfolio based on Prologis' ownership in the properties ("Prologis Share"). The same store population excludes properties held for sale to third parties, along with development properties that were not stabilized at the beginning of the period (January 1, 2024) and properties acquired or disposed of to third parties during the period. To derive an appropriate measure of period-to-period operating performance, we remove the effects of foreign currency exchange rate movements by using the reported period-end exchange rate to translate from local currency into the U.S. dollar, for both periods. As non-GAAP financial measures, the same store metrics have certain limitations as an analytical tool and may vary among real estate companies. As a result, we provide a reconciliation of Rental Revenues less Rental Expenses ("Property NOI") (from our Consolidated Financial Statements prepared in accordance with U.S. GAAP) to our Same Store Property NOI measures, as follows: Three Months Ended Jun. 30, dollars in thousands 20252024Change (%) Reconciliation of Consolidated Property NOI to Same Store Property NOI measures:Rental revenues $ 2,025,332$ 1,852,376 Rental expenses (487,963)(445,235) Consolidated Property NOI $ 1,537,369$ 1,407,141 Adjustments to derive same store results: Property NOI from consolidated properties not included in same store portfolio and other adjustments (a) (217,719)(117,439)Property NOI from unconsolidated co-investment ventures included in same store portfolio (a)(b) 893,689832,222Third parties' share of Property NOI from properties included in same store portfolio (a)(b) (705,623)(683,251) Prologis Share of Same Store Property NOI - Net Effective (b) $ 1,507,716$ 1,438,6734.8 %Consolidated properties straight-line rent and fair value lease amortization included in the same store portfolio (c) (127,131)(120,839)Unconsolidated co-investment ventures straight-line rent and fair value lease amortization included in the same store portfolio (c) (29,930)(19,435)Third parties' share of straight-line rent and fair value lease amortization included in the same store portfolio (b)(c) 23,79312,063 Prologis Share of Same Store Property NOI - Cash (b)(c) $ 1,374,448$ 1,310,4624.9 % (a) We exclude properties held for sale to third parties, along with development properties that were not stabilized at the beginning of the period and properties acquired or disposed of to third parties during the period. We also exclude one-time items due to early lease terminations, including termination fees received from customers and the write-off of related lease assets and liabilities, that are not indicative of the property's recurring operating performance in order to evaluate the growth or decline in each property's rental revenues. Same Store Property NOI is adjusted to include an allocation of property management expenses for our consolidated properties based on the property management services provided to each property (generally, based on a percentage of revenues). On consolidation, these amounts are eliminated and the actual costs of providing property management and leasing services are recognized as part of our consolidated rental expense. (b) We include the Property NOI for the same store portfolio for both consolidated properties and properties owned by the co-investment ventures based on our investment in the underlying properties. In order to calculate our share of Same Store Property NOI from the co-investment ventures in which we own less than 100%, we use the co-investment ventures' underlying Property NOI for the same store portfolio and apply our ownership percentage at June 30, 2025 to the Property NOI for both periods, including the properties contributed during the period. We adjust the total Property NOI from the same store portfolio of the co-investment ventures by subtracting the third parties' share of both consolidated and unconsolidated co-investment the periods presented, certain wholly-owned properties were contributed to a co-investment venture and are included in the same store portfolio. Neither our consolidated results nor those of the co-investment ventures, when viewed individually, would be comparable on a same store basis because of the changes in composition of the respective portfolios from period to period (e.g. the results of a contributed property are included in our consolidated results through the contribution date and in the results of the venture subsequent to the contribution date based on our ownership interest at the end of the period). As a result, only line items labeled "Prologis Share of Same Store Property NOI" are comparable period over period. (c) We further remove certain noncash items (straight-line rent and fair value lease amortization) included in the financial statements prepared in accordance with U.S. GAAP to reflect a Same Store Property NOI – Cash measure. We manage our business and compensate our executives based on the same store results of our Owned and Managed portfolio at 100% as we manage our portfolio on an ownership blind basis. We calculate those results by including 100% of the properties included in our same store portfolio. Stabilization is defined as the earlier of when a property that was developed has been completed for one year, is contributed to a co-investment venture following completion or is 90% occupied. Upon Stabilization, a property is moved into our Operating Portfolio. Total Expected Investment ("TEI") represents total estimated cost of development or expansion, including land, development and leasing costs. TEI is based on current projections and is subject to change. Weighted Average Interest Rate is based on the effective rate, which includes the amortization of related premiums and discounts and finance costs. Weighted Average Stabilized Capitalization ("Cap") Rate is calculated as Stabilized NOI divided by the Acquisition Price. View original content to download multimedia: SOURCE Prologis, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Caylent Renews Strategic Collaboration Agreement with AWS to Deliver Industry-Specific GenAI Solutions
Creation of new industry principal strategists to shape go-to-market strategies and solutions to accelerate customer outcomes NEW YORK, July 16, 2025 /PRNewswire/ -- Caylent, an Amazon Web Services (AWS) Premier Tier Services Partner, today announced a renewed strategic collaboration agreement (SCA) with AWS. The agreement expands investment in AI and industry-specific solutions to accelerate enterprise cloud adoption and generative AI (GenAI) enablement across high-growth verticals including: healthcare and life sciences, financial services, media and entertainment, sports, Software as a Service (SaaS) and Independent Software Vendors (ISVs), travel and hospitality, energy, automotive and manufacturing, education technology and more. As part of this agreement, Caylent is launching 16 new industry-tailored GenAI solutions and significantly growing its industry and AI-focused teams with the creation of new Industry Principal Strategists. These domain experts understand the unique regulatory, operational, and data challenges of each vertical and will guide customers through complex modernization with tailored roadmaps and measurable outcomes. The first four GenAI solutions launching are: Intelligent Document Processing for Financial Services – Transforms financial documents into actionable insights with AI pipelines that automate intake, extraction, and regulatory compliance. Video Understanding for Media & Entertainment – Transforms video into strategic insights with AI that analyzes visuals, audio, and text to drive personalization, engagement, and monetization. Clinical Trial Design Optimizer – Brings precision and speed to trial design by integrating real-world data, AI insights, and regulatory precedent. Cuts trial execution costs 10-20% and accelerates overall development timelines by 5-10% Clinical Document Writer – Reduces regulatory submission documentation time by 40% and costs by 50% by automating clinical writing with AI-powered quality checks and integrated data sources. "Partnering with Caylent was instrumental in bringing our vision for the Trial Intelligence Coordinator to life. Their deep understanding of clinical research workflows, paired with their AI expertise and deep command of AWS services like Amazon Bedrock and Amazon Comprehend Medical, allowed us to build a GenAI co-pilot that transforms how imaging data is accessed, queried, and utilized," said Susan Wood, PhD, CEO at VIDA Diagnostics Inc, "With Caylent's guidance, we are now on a path to a future-ready solution that delivers real-time imaging insights, enhances collaboration across our global research teams, and sets a new bar for improving patient outcomes and therapeutic effectiveness." To expedite AI readiness, Caylent Accelerate™, the company's unique AI-powered delivery approach, unlocks previously impossible transformations and helps companies move faster, reduce costs, and create the IP they need to lead in their industries. Caylent Accelerate automates complex tasks like database migration, code translation, and compliance validation, reducing technical debt and helping enterprises build secure, scalable, AI-ready cloud environments. "As an all-in AWS Premier Tier Services Partner, we're proud to be launching new, purpose-built GenAI solutions across high-growth industries that solve real-world problems," said Caylent President and Chief Revenue Officer Val Henderson. "By adding experienced industry principals and leaders to our team, we are better equipped to guide customers through complex modernization with tailored roadmaps and measurable outcomes. This is just the beginning as we look to expand our smart solution offerings into even more industries in the future." Learn more about each solution at the links below, or visit Caylent at booth #552 at today's AWS Summit New York City. Intelligent Document Processing for Financial Services: Video Understanding for Media & Entertainment: Clinical Trial Design Optimizer: Clinical Document Writer: About CaylentAs an AWS Premier Tier Services Partner, Caylent is shaping the future where AI transforms industries responsibly and with excellence. We help companies build the solutions they need to succeed in today's market while enabling organizational evolution to thrive in a rapidly changing technology landscape. Our AI-enabled delivery methodology combined with our deep AWS experience turns our customers' ideas into impact, faster. Caylent's achievements include being named AWS Migration Consulting Partner of the Year, GenAI Industry Solution Partner of the Year, and Industry Partner of the Year - Financial Services in 2024, Application Modernization Partner of the Year in 2023, AWS Innovation Partner of the Year in 2022, and AWS Rising Star Partner of the Year in 2021. Caylent's services include migrations, modernization, custom software development and generative AI. Learn more at View original content to download multimedia: SOURCE Caylent
Yahoo
20 minutes ago
- Yahoo
Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation
HENDERSON, Nev., July 16, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today provides an update on the significant commercial and scientific progress of its Nu.Q® Discover program. With an estimated total addressable market of $200 million annually [1], Nu.Q® Discover targets a smaller market than our other larger pillars, but it is proving to be a strong source of early revenue and is validating the wide applicability and utility of our Nu.Q® platform with some of the world's biggest healthcare companies. With a powerful portfolio of 14 state-of-the-art immunoassays, Nu.Q® Discover is now serving over 20 clients worldwide, accelerating disease research and drug development across multiple therapeutic areas. Built on Volition's proprietary nucleosome quantification technology, Nu.Q® Discover offers unparalleled insight through high-throughput epigenetic profiling as a service to large Pharma and diagnostic companies for their own development programs. The Nu.Q® platform's versatility across biological samples and disease models was recently validated in a peer-reviewed publication in the Journal of Biological Chemistry titled: "High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development." Volition is committed to expanding the Nu.Q® Discover offering and delivering significant value to the life sciences community. The company anticipates continued growth in 2025, including multiple new contracts, building on the strong foundation of scientific excellence and global commercial traction established to date. Dr. Jasmine Kway, Chief Executive Officer, Singapore Volition said: "We've seen strong and growing demand for Nu.Q® assays as exploratory biomarkers in 3rd parties' multi-national clinical trials, with multiple global clients placing repeat orders. The largest of these projects has projected revenue in the hundreds of thousands of dollars, for an ongoing longitudinal Phase 1/2b study targeting completion in 2026. "Our robust pipeline and ongoing service expansion suggests continued strong Nu.Q® Discover revenue growth this year. "Pharma companies are using Nu.Q® assays as exploratory biomarkers today — and if/when they advance to companion diagnostic use, this could translate into high-value, multi-million dollar, long-term partnerships. "We're also actively exploring co-marketing partnerships to meet the demand for Nu.Q® Discover we are seeing worldwide and hope to be able to sign such a deal in the coming months." About Nu.Q® Discover Nu.Q® Discover empowers pharmaceutical and biotech developers with rapid high-throughput epigenetic profiling across key biological processes. The platform supports the entire drug development continuum—from preclinical studies to clinical validation—with biomarkers designed to: Assess disease severity Monitor treatment response Deepen understanding of disease mechanisms Its applications span oncology, neurodegenerative and autoimmune diseases and NETosis—making it one of the most versatile epigenetic solutions on the market learn more about Nu.Q® Discover or to request a collaboration, visit About Volition Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help detect and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early detection and monitoring have the potential not only to prolong the life of patients, but also to improve their quality of life. Volition's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and an office in London. The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only. Media Enquiries: Louise Batchelor, Volition, mediarelations@ +44 (0)7557 774620 Investor Relations:Jeremy Feffer, LifeSci Advisors, jfeffer@ +1-212-915-2568 Safe Harbor Statement Statements in this press release may be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. Words such as "expects," "anticipates," "intends," "plans," "aims," "targets," "believes," "seeks," "estimates," "optimizing," "potential," "goal," "suggests," "could," "would," "should," "may," "will" and similar expressions identify forward-looking statements. These forward-looking statements relate to, among other topics, the total addressable market for Nu.Q® Discover, , Volition's expectations related to revenue opportunities and growth, the timing, completion, success and delivery of data from clinical studies, the effectiveness and availability of Volition's blood-based diagnostic, prognostic and disease monitoring tests, Volition's ability to develop and successfully commercialize such test platforms for early detection of cancer and other diseases as well as serving as a diagnostic, prognostic or disease monitoring tools for such diseases, and Volition's success in securing licensing, distribution and/or other agreements with third parties for its products. Volition's actual results may differ materially from those indicated in these forward-looking statements due to numerous risks and uncertainties, including, without limitation, results of studies testing the efficacy of its tests. For instance, if Volition fails to develop and commercialize diagnostic, prognostic or disease monitoring products, it may be unable to execute its plan of operations. Other risks and uncertainties include Volition's failure to obtain necessary regulatory clearances or approvals to distribute and market future products; a failure by the marketplace to accept the products in Volition's development pipeline or any other diagnostic, prognostic or disease monitoring products Volition might develop; Volition's failure to secure adequate intellectual property protection; Volition will face fierce competition and Volition's intended products may become obsolete due to the highly competitive nature of the diagnostics and disease monitoring market and its rapid technological change; downturns in domestic and foreign economies; and other risks, including those identified in Volition's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as other documents that Volition files with the Securities and Exchange Commission. These statements are based on current expectations, estimates and projections about Volition's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Forward-looking statements are made as of the date of this release, and, except as required by law, Volition does not undertake an obligation to update its forward-looking statements to reflect future events or circumstances. Nucleosomics™, Capture-PCR™, Capture-Seq™ and Nu.Q® and their respective logos are trademarks and/or service marks of VolitionRx Limited and its subsidiaries. All other trademarks, service marks and trade names referred to in this press release are the property of their respective owners. Additionally, unless otherwise specified, all references to "$" refer to the legal currency of the United States of America. [1] Data on file, Volition Total Addressable Market Model Photo: View original content to download multimedia: SOURCE VolitionRx Limited
